DarioHealth Announced New Chairman of the Board
DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today Yoav Shaked has joined the Company as Chairman of the Board. The Company’s Chief Executive Officer, Erez Raphael shall continue serving on the board of directors and as CEO.
Mr. Shaked is a partner at Sequoia Capital, a world leading venture capital firm. Over the past 20 years he has built and sold companies in the medical technology space. He founded and served as Chief Executive Officer of Y-Med through its sale to C.R. Bard. Mr. Shaked has served at executive positions at XTechnologies a cardiovascular device developer until it was sold to Guidant and as a Director of Research at ThermopeutiX, a developer of innovative products for strokes and peripheral artery disease. He serves on the board of directors of several biotechnology companies including Endospan, Vibrant Gastro, B-Lite (G&G Biotechnology) and Orasis Pharmaceuticals, where he is Chairman of the Board.
“We are honored to welcome Yoav Shaked to our board as Chairman and we believe the move shows his strong belief in DarioHealth’s vision to transform the management of chronic disease through digital health systems. His wealth of experience recognizing promising healthcare technologies and building profitable companies around them will be an asset that helps drive DarioHealth into a market leadership position in digital healthcare technologies,” stated DarioHealth CEO Erez Raphael.
DarioHealth Chairman Mr. Shaked commented, “Digital health technologies have the potential to revolutionize healthcare. Like most other digital platforms, user engagement is key. When a digital health solution becomes a patient’s daily companion and assistant that is when it is truly differentiated and becomes an essential presence in the life of the patient. DarioHealth has achieved this level of engagement with tens of thousands of users today and I believe they can be the dominant player in the management of chronic disease through digital health platforms.”
